BriefCase vs DeepCT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

BriefCase

by Aidoc Medical

DeepCT

by Deep01 Limited

AI Verdict

BriefCase is an AI-powered communication and collaboration solution designed to streamline the sharing of critical medical imaging findings among care teams, relying on AI detection from its parent platform. DeepCT is an AI software focused on the rapid detection and triage of specific brain abnormalities from CT scans. While both contribute to clinical decision support and case prioritization, DeepCT provides the initial AI-driven diagnostic insight, whereas BriefCase facilitates the downstream communication and management of critical findings.

Choose BriefCase if…

Choose BriefCase if your large hospital or health system requires a comprehensive, AI-powered solution to streamline communication and collaboration across care teams for a wide range of critical medical imaging findings. This tool excels at ensuring timely dissemination of urgent results, automating follow-up, and providing a robust audit trail for all critical case communications, integrating seamlessly with existing clinical workflows.

View BriefCase →

Choose DeepCT if…

Choose DeepCT if your emergency department or radiology practice needs to rapidly detect and prioritize acute neurological conditions, such as intracranial hemorrhage, acute stroke, or traumatic brain injury, from non-contrast CT scans. This specialized AI software is ideal for improving emergency workflow by providing immediate notifications, segmenting findings, and prioritizing worklists for time-sensitive brain abnormalities.

View DeepCT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	BriefCase	DeepCT
Pricing	Enterprise	Contact for details
Deployment	Cloud	Cloud-based, Hybrid solution, Locally on dedicated hardware, Integration in standard reading environment (PACS), Stand-alone third party application, Stand-alone web-based
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

BriefCase

BriefCase (Tool A) offers a broader scope of user interaction with its focus on communication, collaboration, and mobile access for care teams, extending beyond just radiologists. Its 'mobile app: both' feature suggests a more flexible and accessible user experience for a wider range of healthcare professionals, facilitating real-time information sharing. DeepCT (Tool B) is primarily focused on detection and notification within the radiology workflow, which is more specialized.

Clinical Value

DeepCT

DeepCT (Tool B) provides direct diagnostic aid for multiple life-threatening conditions like intracranial hemorrhage, midline shift, and acute stroke, including segmentation and quantification of findings. This direct diagnostic contribution for critical brain pathologies offers a more immediate and quantifiable clinical impact on patient diagnosis and treatment initiation. BriefCase (Tool A) primarily enhances the communication and workflow around critical findings, which is valuable but less direct in its diagnostic contribution.

Pricing & Value

BriefCase

While neither tool discloses specific pricing, BriefCase (Tool A) offers more transparency regarding its pricing model, stating it's custom enterprise pricing based on hospital size, modules, and integration requirements. This provides potential customers with a clearer understanding of the factors influencing cost. DeepCT (Tool B) only states 'Contact for details' and 'Not disclosed,' offering no insight into its pricing approach.

Enterprise Readiness

BriefCase

BriefCase (Tool A) demonstrates stronger enterprise readiness with explicit 'yes' confirmations for BAA, HIPAA compliance, SOC2, and GDPR, along with a large customer base of 500+ hospitals globally. It also highlights seamless integration with PACS, RIS, and EHR systems. DeepCT (Tool B) lists BAA and HIPAA compliance as 'Likely, contact vendor for details,' which is less definitive, despite offering flexible deployment options.

Innovation

DeepCT

DeepCT (Tool B) showcases a higher degree of innovation in its direct application of AI for multi-pathology detection, segmentation, and quantification of critical brain conditions from CT scans. This represents a more advanced and specialized use of AI in direct medical image interpretation. BriefCase (Tool A) innovates in applying AI to streamline communication and collaboration workflows, which is valuable but less focused on novel diagnostic AI capabilities.

Support & Docs

Tie

Both Aidoc (for BriefCase) and Deep01 (for DeepCT) indicate the availability of customer support and success teams. Aidoc mentions providing training and educational content, and dedicated customer success teams. Deep01 also states they offer 24/7 technical support and dedicated customer success managers. Without more specific comparative details on the depth, quality, or accessibility of their documentation and support resources, it is not possible to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	BriefCase	DeepCT
Name	BriefCase	DeepCT
Company	Aidoc Medical	Deep01 Limited
Description	FDA-cleared AI-powered communication and collaboration solution integrated into the Aidoc platform, designed to streamline the sharing of critical medical imaging findings among care teams.	FDA-cleared AI software for the rapid detection and triage of suspected intracranial hemorrhage (ICH) and other brain abnormalities from non-contrast CT scans, aiming to improve emergency workflow and patient outcomes.
Key Features	AI-driven critical finding detection (via Aidoc platform), Secure, real-time communication of findings, Customizable communication protocols, Automated follow-up tracking and reminders, Seamless integration with PACS, RIS, and EHR systems, Comprehensive audit trails for all communications, Prioritization of urgent cases for immediate attention, Mobile access for care team collaboration	Detection of intracranial hemorrhage (ICH), Notification to clinicians for suspected findings, Segmentation and quantification of ICH, Worklist prioritization for time-sensitive cases, Detection of midline shift, Detection of acute stroke, Detection of traumatic brain injury (TBI), Detection of fractures
Specialties	Cardiology, Emergency Medicine, Neurology, Pulmonology, Radiology	Emergency Medicine, Neurology, Radiology
Mobile App	both	Not specified

Videos

Demos, reviews, and walkthroughs featuring BriefCase and DeepCT.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in the core functionality of these two tools?

BriefCase by Aidoc is an AI-powered communication and collaboration solution designed to streamline the sharing of critical medical imaging findings among care teams across various specialties. DeepCT by Deep01 Limited is an AI software focused on the rapid detection, triage, segmentation, and quantification of suspected intracranial hemorrhage and other brain abnormalities from non-contrast CT scans.

Which medical specialties and types of findings do these tools support?

BriefCase supports a broad range of specialties including Cardiology, Emergency Medicine, Neurology, Pulmonology, and Radiology, leveraging AI for critical finding detection across these areas. DeepCT is specialized for neurological findings, specifically detecting intracranial hemorrhage, midline shift, acute stroke, traumatic brain injury (TBI), and fractures from head CT scans.

What communication and collaboration features are offered by each tool?

BriefCase provides secure, real-time communication of findings, customizable communication protocols, automated follow-up tracking and reminders, and comprehensive audit trails for all communications. DeepCT's communication feature is primarily focused on providing notifications to clinicians for suspected findings.

Do these tools offer mobile access for care teams?

BriefCase explicitly states it offers mobile access for care team collaboration, supporting both mobile app types. The provided information for DeepCT does not specify whether mobile app availability is offered.

What specific AI detection capabilities does each tool provide?

BriefCase's AI capabilities are described as 'AI-driven critical finding detection' via the Aidoc platform, prioritizing urgent cases across multiple specialties. DeepCT offers specific AI detection for intracranial hemorrhage, midline shift, acute stroke, traumatic brain injury, and fractures, along with segmentation and quantification of ICH.

Are there differences in data export capabilities?

BriefCase explicitly states that data export is available as a feature. The provided information for DeepCT does not specify whether data export functionality is available.